IL172015A - Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infection - Google Patents
Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infectionInfo
- Publication number
- IL172015A IL172015A IL172015A IL17201505A IL172015A IL 172015 A IL172015 A IL 172015A IL 172015 A IL172015 A IL 172015A IL 17201505 A IL17201505 A IL 17201505A IL 172015 A IL172015 A IL 172015A
- Authority
- IL
- Israel
- Prior art keywords
- medicaments
- manufacture
- preparation
- viral infection
- treating viral
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47889303P | 2003-06-16 | 2003-06-16 | |
| PCT/CZ2004/000034 WO2004111064A1 (en) | 2003-06-16 | 2004-06-16 | Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL172015A0 IL172015A0 (en) | 2009-02-11 |
| IL172015A true IL172015A (en) | 2016-07-31 |
Family
ID=33551859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL172015A IL172015A (en) | 2003-06-16 | 2005-11-17 | Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infection |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7115592B2 (enExample) |
| EP (1) | EP1644389B1 (enExample) |
| JP (2) | JP5280631B2 (enExample) |
| KR (1) | KR101102815B1 (enExample) |
| CN (1) | CN1805966B (enExample) |
| AT (1) | ATE496056T1 (enExample) |
| AU (1) | AU2004247305B2 (enExample) |
| CA (1) | CA2527805C (enExample) |
| DE (1) | DE602004031115D1 (enExample) |
| DK (1) | DK1644389T3 (enExample) |
| EA (1) | EA011948B1 (enExample) |
| IL (1) | IL172015A (enExample) |
| NZ (1) | NZ543864A (enExample) |
| SI (1) | SI1644389T1 (enExample) |
| WO (1) | WO2004111064A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2616314A1 (en) * | 2005-07-27 | 2007-02-01 | Gilead Sciences, Inc. | Antiviral phosphonate conjugates for inhibition of hiv |
| FR2908133B1 (fr) * | 2006-11-08 | 2012-12-14 | Centre Nat Rech Scient | Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux |
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| CN102939291B (zh) | 2010-04-14 | 2016-09-07 | 加利福尼亚大学董事会 | 用于病毒感染治疗的具有降低的毒性的膦酸酯 |
| CN103209985B (zh) * | 2010-08-31 | 2016-08-24 | 奇默里克斯公司 | 膦酸酯衍生物及其合成方法 |
| CN105999275A (zh) | 2010-09-01 | 2016-10-12 | 诺华有限公司 | 免疫增强剂吸附不溶性金属离子 |
| FI2648701T3 (fi) | 2010-12-10 | 2023-06-12 | Sigmapharm Laboratories Llc | Hyvin stabiileja adefovirdipivoksiilin koostumuksia |
| US20140112950A1 (en) | 2011-03-02 | 2014-04-24 | Manmohan Singh | Combination vaccines with lower doses of antigen and/or adjuvant |
| US9593137B2 (en) | 2011-12-22 | 2017-03-14 | Geron Corporation | Guanine analogs as telomerase substrates and telomere length affectors |
| US9375471B2 (en) | 2012-03-08 | 2016-06-28 | Glaxosmithkline Biologicals Sa | Adjuvanted formulations of booster vaccines |
| CN103665043B (zh) * | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药及其在医药上的应用 |
| CN102796138B (zh) * | 2012-09-07 | 2014-10-22 | 山东大学 | (2-(3-甲硫基-1,2,4-噻二嗪)乙氧基)甲基膦酸酯类衍生物及其制备与应用 |
| JP6462659B2 (ja) | 2013-03-15 | 2019-01-30 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 非環式ヌクレオシドホスホン酸ジエステル |
| CN112898345A (zh) | 2014-09-15 | 2021-06-04 | 加利福尼亚大学董事会 | 核苷酸类似物 |
| EP3350191B9 (en) | 2015-09-15 | 2021-12-22 | The Regents of the University of California | Nucleotide analogs |
| CA3262284A1 (en) | 2022-07-21 | 2024-01-25 | Antiva Biosciences Inc | Pharmaceutical compositions and forms for the treatment of human papillomavirus (HPV) infection and HPV-induced neoplasm |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS233665B1 (en) | 1983-01-06 | 1985-03-14 | Antonin Holy | Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene |
| DE3580384D1 (de) | 1984-04-09 | 1990-12-13 | Toyo Boseki | Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle. |
| CS263951B1 (en) | 1985-04-25 | 1989-05-12 | Antonin Holy | 9-(phosponylmethoxyalkyl)adenines and method of their preparation |
| CS263952B1 (en) | 1985-04-25 | 1989-05-12 | Holy Antonin | Remedy with antiviral effect |
| JPS63501194A (ja) * | 1985-10-30 | 1988-05-12 | プラネルト・イエンス | 歯の残根から冠，ブリツジ等を除去するための装置 |
| US5141752A (en) | 1986-05-09 | 1992-08-25 | Alza Corporation | Delayed drug delivery device |
| CS264222B1 (en) | 1986-07-18 | 1989-06-13 | Holy Antonin | N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them |
| NZ222553A (en) | 1986-11-18 | 1991-07-26 | Bristol Myers Co | Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions |
| CA2001715C (en) | 1988-11-14 | 1999-12-28 | Muzammil M. Mansuri | Carbocyclic nucleosides and nucleotides |
| US5098443A (en) | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
| CA2297294C (en) | 1989-05-15 | 2005-11-08 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Phosphonomethoxymethylpurine/pyrimidine derivatives |
| MY104575A (en) | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| US5302585A (en) | 1990-04-20 | 1994-04-12 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents |
| CZ285420B6 (cs) | 1990-04-24 | 1999-08-11 | Ústav Organické Chemie A Biochemie Avčr | N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití |
| WO1992001698A1 (en) | 1990-07-19 | 1992-02-06 | Beecham Group Plc | Antiviral phosphono-alken derivatives of purines |
| EP0468119A1 (en) | 1990-07-24 | 1992-01-29 | Merrell Dow Pharmaceuticals Inc. | Novel carbocyclic analogs of certain nucleosides |
| DE10399025I2 (de) | 1990-09-14 | 2007-11-08 | Acad Of Science Czech Republic | Wirkstoffvorläufer von Phosphonaten |
| US5208221A (en) | 1990-11-29 | 1993-05-04 | Bristol-Myers Squibb Company | Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
| US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| CZ284678B6 (cs) | 1991-05-20 | 1999-01-13 | Ústav Organické Chemie A Biochemie Avčr | Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití |
| DE69218968T2 (de) | 1991-10-11 | 1997-10-09 | Inst Of Organic Chemistry And | Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate |
| US6057305A (en) | 1992-08-05 | 2000-05-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Antiretroviral enantiomeric nucleotide analogs |
| EP0618214A1 (en) | 1993-04-01 | 1994-10-05 | Merrell Dow Pharmaceuticals Inc. | Unsaturated phosphonate derivatives of purines and pyrimidines |
| CA2171743C (en) | 1993-09-17 | 2007-11-20 | Norbert W. Bischofberger | Nucleotide analogs |
| SI9620042A (sl) | 1995-02-27 | 1998-12-31 | Gilead Sciences, Inc. | Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz |
| US5977061A (en) | 1995-04-21 | 1999-11-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | N6 - substituted nucleotide analagues and their use |
| JP4033494B2 (ja) | 1996-07-26 | 2008-01-16 | ギリヤド サイエンシーズ， インコーポレイテッド | ヌクレオチドアナログ |
| MXPA04000138A (es) * | 2001-06-29 | 2005-06-06 | Acad Of Science Czech Republic | Compuestos novedosos y metodos de trabajo. |
-
2004
- 2004-06-16 SI SI200431649T patent/SI1644389T1/sl unknown
- 2004-06-16 WO PCT/CZ2004/000034 patent/WO2004111064A1/en not_active Ceased
- 2004-06-16 NZ NZ543864A patent/NZ543864A/en not_active IP Right Cessation
- 2004-06-16 EP EP04738454A patent/EP1644389B1/en not_active Expired - Lifetime
- 2004-06-16 KR KR1020057024279A patent/KR101102815B1/ko not_active Expired - Lifetime
- 2004-06-16 DK DK04738454.0T patent/DK1644389T3/da active
- 2004-06-16 EA EA200600046A patent/EA011948B1/ru not_active IP Right Cessation
- 2004-06-16 AT AT04738454T patent/ATE496056T1/de not_active IP Right Cessation
- 2004-06-16 DE DE602004031115T patent/DE602004031115D1/de not_active Expired - Lifetime
- 2004-06-16 CN CN2004800168859A patent/CN1805966B/zh not_active Expired - Lifetime
- 2004-06-16 AU AU2004247305A patent/AU2004247305B2/en not_active Expired
- 2004-06-16 US US10/869,005 patent/US7115592B2/en not_active Expired - Lifetime
- 2004-06-16 JP JP2006515644A patent/JP5280631B2/ja not_active Expired - Lifetime
- 2004-06-16 CA CA2527805A patent/CA2527805C/en not_active Expired - Lifetime
-
2005
- 2005-11-17 IL IL172015A patent/IL172015A/en active IP Right Grant
-
2006
- 2006-06-23 US US11/473,924 patent/US20060241081A1/en not_active Abandoned
-
2012
- 2012-05-21 JP JP2012115602A patent/JP2012153731A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060041182A (ko) | 2006-05-11 |
| NZ543864A (en) | 2009-10-30 |
| JP5280631B2 (ja) | 2013-09-04 |
| CA2527805C (en) | 2012-08-21 |
| CN1805966B (zh) | 2013-03-13 |
| US20050075318A1 (en) | 2005-04-07 |
| SI1644389T1 (sl) | 2011-06-30 |
| CN1805966A (zh) | 2006-07-19 |
| EP1644389A1 (en) | 2006-04-12 |
| US7115592B2 (en) | 2006-10-03 |
| AU2004247305A1 (en) | 2004-12-23 |
| IL172015A0 (en) | 2009-02-11 |
| DK1644389T3 (da) | 2011-05-09 |
| EP1644389B1 (en) | 2011-01-19 |
| DE602004031115D1 (de) | 2011-03-03 |
| EA200600046A1 (ru) | 2006-06-30 |
| KR101102815B1 (ko) | 2012-01-05 |
| JP2012153731A (ja) | 2012-08-16 |
| AU2004247305B2 (en) | 2010-02-18 |
| US20060241081A1 (en) | 2006-10-26 |
| WO2004111064A1 (en) | 2004-12-23 |
| JP2006527702A (ja) | 2006-12-07 |
| CA2527805A1 (en) | 2004-12-23 |
| EA011948B1 (ru) | 2009-06-30 |
| HK1088013A1 (en) | 2006-10-27 |
| ATE496056T1 (de) | 2011-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL172015A (en) | Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infection | |
| MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
| SE0200920D0 (sv) | Novel compounds | |
| TNSN04199A1 (en) | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use | |
| SE0104140D0 (sv) | Novel Compounds | |
| WO2002098865A3 (fr) | Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs | |
| MXPA03011972A (es) | Arilaminas para tratamiento de condiciones asociadas con gsk-3. | |
| YU27304A (sh) | Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova | |
| WO2003016282A3 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
| CY1105410T1 (el) | Υποκατεστημενες 2-φαινυλοβενζιμιδαζολες, η παρασκευη και η εφαρμογη τους | |
| SE0102438D0 (sv) | New compounds | |
| MY134582A (en) | New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments | |
| MXPA04000886A (es) | Derivados de triazolil-imidazopiridina y triazolilpurinas empledos como ligandos del receptor de adenosina a2a y su uso como medicamentos. | |
| WO2005084192A3 (en) | Novel 2’-c-methyl nucleoside derivatives | |
| TW200604197A (en) | New compounds | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| PL372117A1 (en) | N-benzoylureidocinnamate derivatives, method for production and use thereof | |
| SE0101038D0 (sv) | Novel compounds | |
| MXPA04004621A (es) | Nucleotidos, preparaciones de los mismos y su utilizacion como inhibidores de polimerasas virales de arn. | |
| AU2003300385A8 (en) | Anticancer compounds | |
| TR200302288T2 (tr) | Terapi için yeni bileşikler ve metotlar. | |
| IL166057A0 (en) | Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments | |
| MXPA03010120A (es) | Arilcetonas substituidas. | |
| SE0202693D0 (sv) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |